John J.V. McMurray
University of Glasgow
Publications 1608
#1Susan Stienen (University of Lorraine)
#2João Pedro Ferreira (University of Lorraine)H-Index: 12
Last.Patrick Rossignol (University of Lorraine)H-Index: 40
view all 10 authors...
Background In patients with acute myocardial infarction (MI), BMI < 18.5 kg/m2 and a decrease in BMI during follow-up have been associated with poor prognosis. For BMI ≥ 25 kg/m2, an “obesity paradox” has been suggested. Recently, high visit-to-visit BMI variability has also been associated with poor prognosis in patients with coronary artery disease.
#1Senthil Selvaraj (HUP: Hospital of the University of Pennsylvania)H-Index: 11
#2Brian ClaggettH-Index: 37
Last.Martin Lefkowitz (Novartis)H-Index: 34
view all 15 authors...
Background: The contemporary prognostic value of the physical examination, beyond traditional risk factors including natriuretic peptides (NPs), risk scores, and symptoms, in heart failure with red...
#1Søren Lund Kristensen (Glas.: University of Glasgow)H-Index: 18
#2Rasmus Rørth (Glas.: University of Glasgow)H-Index: 3
Last.John J.V. McMurray (Glas.: University of Glasgow)H-Index: 146
view all 0 authors...
Summary Background Glucagon-like peptide-1 (GLP-1) receptor agonists differ in their structure and duration of action and have been studied in trials of varying sizes and with different patient populations, with inconsistent effects on cardiovascular outcomes reported. We aimed to synthesise the available evidence by doing a systematic review and meta-analysis of cardiovascular outcome trials of these drugs. Methods We searched MEDLINE (via PubMed) and the Cochrane Central Register of Controlled...
#1Elke PlatzH-Index: 16
#2Ross T. CampbellH-Index: 11
Last.Montane B. SilvermanH-Index: 1
view all 0 authors...
Abstract Objectives This study sought to assess the prevalence, changes in, and prognostic importance of B-lines, a pulmonary congestion measure by using a simplified lung ultrasonography (LUS) method in acute heart failure (AHF). Background Pulmonary congestion is an important finding in AHF, but conventional methods for its detection are insensitive. Methods In a 2-site, prospective, observational study, 4-zone LUS was performed early during hospitalization for AHF (LUS1) and at discharge (LUS...
#1Matthew M.Y. Lee (Glas.: University of Glasgow)H-Index: 4
#2Naveed Sattar (Glas.: University of Glasgow)H-Index: 115
Last.Chris J. Packard (Glas.: University of Glasgow)H-Index: 91
view all 0 authors...
Purpose of Review We summarize the best evidence for statins in the prevention and treatment of heart failure.
#1Alvin Chandra (Harvard University)
#2Muthiah Vaduganathan (Harvard University)H-Index: 28
Last.Ge JunboH-Index: 40
view all 23 authors...
Abstract Objectives This study sought to describe baseline health-related quality of life (HRQL) in the PARAGON-HF (Prospective Comparison of ARNI with ARB Global Outcomes in HFpEF) trial, the largest heart failure with preserved ejection fraction (HFpEF) trial to date. Background There are limited data characterizing HRQL in patients with HFpEF using validated metrics. Methods The PARAGON-HF trial randomized symptomatic patients with HFpEF (≥45%) ≥50 years of age to either sacubitril/valsartan ...
#1Anders JorsalH-Index: 16
#2Kasper PrydsH-Index: 5
Last.Roni NielsenH-Index: 12
view all 0 authors...
Background Device therapy in addition to medical treatment improves prognosis in a subset of patients with heart failure and reduced ejection fraction. However, some patients remain symptomatic or their heart failure even progresses despite cardiac resynchronization therapy (CRT). The aim of the study was to evaluate the proportion of patients who could benefit from optimization of medical therapy using sacubitril/valsartan, ivabradine, or both following CRT implantation.